The role and mechanism of KMT2D to modulate PI3Kα inhibitor response in cervical cancer identified by CRISPR/Cas9 genome-wide screening

被引:0
|
作者
Chen, Chen Lihua [1 ]
Li, Li Jiajia [1 ]
Wu, Wu Xiaohua [1 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
关键词
D O I
10.1136/ijgc-2024-ESGO.177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
542
引用
收藏
页码:A98 / A99
页数:2
相关论文
共 44 条
  • [41] A CRISPR-Cas9 BASED GENOME-WIDE SCREENING IDENTIFIED NOVEL TARGETS FOR TREATING SORAFENIB-RESISTANT HEPATOCELLULAR CARCINOMA: CROSS-TALK OF FGF21 AND NRF2 PATHWAY
    Chen, Jiang
    Jiang, Shi
    Li, Bixia
    Ji, Tong
    Staiculescu, Daniel
    He, Jiayan
    Xu, Junjie
    Cai, Xiujun
    HEPATOLOGY, 2021, 74 : 128A - 129A
  • [42] CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma:a cross-talk between FGF21 and the NRF2 pathway
    Jiang Chen
    Shi Jiang
    Huijiang Shao
    Bixia Li
    Tong Ji
    Daniel Staiculescu
    Jiayan He
    Jie Zhao
    Liuxin Cai
    Xiao Liang
    Junjie Xu
    Xiujun Cai
    Science China(Life Sciences), 2022, 65 (10) : 1998 - 2016
  • [43] CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway
    Chen, Jiang
    Jiang, Shi
    Shao, Huijiang
    Li, Bixia
    Ji, Tong
    Staiculescu, Daniel
    He, Jiayan
    Zhao, Jie
    Cai, Liuxin
    Liang, Xiao
    Xu, Junjie
    Cai, Xiujun
    SCIENCE CHINA-LIFE SCIENCES, 2022, 65 (10) : 1998 - 2016
  • [44] CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway
    Jiang Chen
    Shi Jiang
    Huijiang Shao
    Bixia Li
    Tong Ji
    Daniel Staiculescu
    Jiayan He
    Jie Zhao
    Liuxin Cai
    Xiao Liang
    Junjie Xu
    Xiujun Cai
    Science China Life Sciences, 2022, 65 : 1998 - 2016